PANELS
Neurology
Home > Neurology
Overview
Our virtual panels include over 3,000 genes selected based on the most up-to-date literature, gene reviews and variant databases. Our whole genome approach offers cost-effectiveness by reducing the need for multiple targeted tests, and maximises diagnostic yield by allowing you to combine panels, select individual genes, and surface variants across all regions of the genome.
Genetics in Neurology
Virtual panel tests can assist in diagnosing a wide range of inherited neurological disorders, including muscular dystrophies, hereditary neuropathies, ataxias, and inherited epilepsy syndromes. These tests can identify specific genetic mutations responsible for these conditions, helping confirm diagnoses and guide treatment decisions.
For neurodegenerative diseases such as Huntington’s disease or certain forms of early-onset Alzheimer’s disease, genetic panel tests can facilitate early diagnosis and intervention, allowing patients and families to make informed decisions about their healthcare and future planning.
In cases where patients present with complex neurological symptoms that do not fit a clear clinical pattern, genetic panel tests can identify rare genetic syndromes that may otherwise be challenging to diagnose.
Genetic panel tests are particularly useful in the diagnosis and management of epilepsy, as they can identify genetic variants associated with various forms of the condition. This information can guide treatment choices and prognosis assessments.
While genetic panel tests are highly valuable in neurology, it’s essential to interpret their results in the context of a patient’s clinical presentation and other diagnostic tests. We recommend working closely with genetic counselors and other specialists to ensure that genetic information is used effectively to diagnose, treat, and manage neurological conditions.
For further information on tailoring treatment plans to an individual’s genetic profile, leading to improved outcomes and reduced side effects, please visit our pharmacogenomics page.